MX2022011025A - Procesos para producir compuestos de amida, y su forma cristalina y de sal. - Google Patents

Procesos para producir compuestos de amida, y su forma cristalina y de sal.

Info

Publication number
MX2022011025A
MX2022011025A MX2022011025A MX2022011025A MX2022011025A MX 2022011025 A MX2022011025 A MX 2022011025A MX 2022011025 A MX2022011025 A MX 2022011025A MX 2022011025 A MX2022011025 A MX 2022011025A MX 2022011025 A MX2022011025 A MX 2022011025A
Authority
MX
Mexico
Prior art keywords
amide compounds
crystalline
processes
salt form
producing amide
Prior art date
Application number
MX2022011025A
Other languages
English (en)
Inventor
Cheng- Ho Chung
Shi- Liang TSENG
Hsiang- En Hsu
Original Assignee
Alphala Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alphala Co Ltd filed Critical Alphala Co Ltd
Publication of MX2022011025A publication Critical patent/MX2022011025A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/107—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with two aryl or substituted aryl radicals attached in positions 2 and 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C313/00—Sulfinic acids; Sulfenic acids; Halides, esters or anhydrides thereof; Amides of sulfinic or sulfenic acids, i.e. compounds having singly-bound oxygen atoms of sulfinic or sulfenic groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C313/02—Sulfinic acids; Derivatives thereof
    • C07C313/06—Sulfinamides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Se describen procesos para producir compuestos de amida, y su forma cristalina y de sal; en la presente, uno de los compuestos de amida se representa por la siguiente fórmula (1), (ver Fórmula) (1) que se caracteriza por un patrón de difracción de rayos X (XRD) que tiene picos a aproximadamente 14.2, 15.6, 16.4, 20.1, 20.5 y 21.2° ± 0.2° 2?.
MX2022011025A 2020-03-06 2021-03-03 Procesos para producir compuestos de amida, y su forma cristalina y de sal. MX2022011025A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202062985918P 2020-03-06 2020-03-06
PCT/US2021/020595 WO2021178486A1 (en) 2020-03-06 2021-03-03 Processes for producing amide compounds, and their crystalline and salt form

Publications (1)

Publication Number Publication Date
MX2022011025A true MX2022011025A (es) 2022-10-07

Family

ID=77613709

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022011025A MX2022011025A (es) 2020-03-06 2021-03-03 Procesos para producir compuestos de amida, y su forma cristalina y de sal.

Country Status (12)

Country Link
US (1) US20230131180A1 (es)
EP (1) EP4114823A4 (es)
JP (1) JP2023516082A (es)
KR (1) KR20220137084A (es)
CN (1) CN115052855A (es)
AU (2) AU2021231787B2 (es)
BR (1) BR112022015507A2 (es)
CA (1) CA3170348A1 (es)
IL (1) IL296041A (es)
MX (1) MX2022011025A (es)
TW (1) TWI787751B (es)
WO (1) WO2021178486A1 (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2822017C (en) * 2010-12-23 2015-04-07 Pfizer Inc. Glucagon receptor modulators
DK2673260T3 (en) * 2011-02-08 2016-10-10 Pfizer Glucagonreceptormodulator
EA039455B1 (ru) * 2017-01-24 2022-01-28 Алфала Ко., Лтд. Амидные соединения и их применение
JP6906105B2 (ja) * 2017-06-16 2021-07-21 成都先導薬物開発股▲ふん▼有限公司Ｈｉｔｇｅｎ Ｌｔｄ． Ｒｏｃｋを阻害する化合物及びその使用

Also Published As

Publication number Publication date
EP4114823A4 (en) 2024-06-19
WO2021178486A1 (en) 2021-09-10
EP4114823A1 (en) 2023-01-11
IL296041A (en) 2022-10-01
CN115052855A (zh) 2022-09-13
KR20220137084A (ko) 2022-10-11
AU2023266374A1 (en) 2023-12-07
AU2021231787A1 (en) 2022-08-25
TW202142534A (zh) 2021-11-16
AU2021231787B2 (en) 2023-08-17
TWI787751B (zh) 2022-12-21
BR112022015507A2 (pt) 2022-09-27
US20230131180A1 (en) 2023-04-27
CA3170348A1 (en) 2021-09-10
JP2023516082A (ja) 2023-04-17

Similar Documents

Publication Publication Date Title
MX2020009612A (es) Polimorfos de sal de calcio novedosos como agentes anti-inflamatorios, inmunomoduladores y anti-proliferativos.
AP1537A (en) A crystalline form of perindopril tert-butylamine salt.
CR20220354A (es) Inhibidores de egfr
MX2019011147A (es) Forma cristalina hidratada del ácido 2-acrilamido-2-metilpropano sulfónico.
RU2014110399A (ru) Кристаллические формы вгс протеазного ингибитора
HRP20230813T1 (hr) Upadacitinib solni spoj i postupak njegove pripreme
MY139399A (en) Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
JP2015514060A5 (es)
NZ594408A (en) Crystalline form of r)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate
EA017861B9 (ru) Способ получения 4-оксохинолинового соединения
RU2012146517A (ru) Соли ральтегравира и их кристаллические формы
EA201370184A1 (ru) Гетероарильные производные
MX2023004731A (es) Forma cristalina iv del compuesto agonista de receptor de melanocortina y metodo de preparacion para la misma.
BR112022009390A2 (pt) Síntese melhorada de composto inibidor de kras g12c
MX2023004732A (es) Forma cristalina iii del compuesto agonista de receptor de melanocortina y metodo de preparacion para la misma.
HRP20130950T1 (hr) Trans-4-[[(5s)-5-[[[3,5-bis(trifluormetil)fenil]metil](2-metil-2h-tetrazol-5-il)amino]-2,3,4,5-tetrahidro-7,9-dimetil-1h-1-benzazepin-1-il]metil]cikloheksankarboksilna kiselina
WO2018232005A3 (en) Antimicrobial compounds and nanostructures
MX2022011025A (es) Procesos para producir compuestos de amida, y su forma cristalina y de sal.
CY1126057T1 (el) Νεο αλας ενος αναστολεα bcl-2, σχετικη κρυσταλλικη μορφη, μεθοδος για παρασκευη αυτοy kai φαρμακευτικες συνθεσεις που περιεχουν αυτο
MX2022000164A (es) Inhibidores de tirosina cinasa no receptora 1 (tnk1) y usos de los mismos.
GB2605894A (en) 5-chloro-4-hydroxy-1-methyl-2-oxo-n-phenyl-quinoline-3-carboxamide potassium salt
MX2023005889A (es) Inhibidor de integrina y usos de este.
MX2021014271A (es) Sales farmaceuticamente aceptables de [2-(3-fluoro-5-metanosulfoni lfenoxi)etil](propil)amina y usos de las mismas.
CO2023006514A2 (es) Agonista de receptor de melanocortina-4 amorfo
EA201290156A1 (ru) Комплексы вилдаглиптина с неорганической солью